Investment Thesis — Ameren Corporation
The market is dramatically mispricing Ameren's risk profile, evidenced by an extraordinary 342% short interest that suggests deep fundamental issues. We believe this extreme bearish sentiment overlooks the inherent stability of a regulated utility and sets the stage for a powerful short squeeze.
Catalysts
- Initiation of a short squeeze due to positive news or market shift
- Favorable regulatory rate case outcomes boosting future earnings
- Stronger-than-expected earnings and guidance driving short covering
Risk Factors
- Sustained high interest rates reducing appeal of dividend stocks
- Adverse regulatory decisions impacting rate base or allowed returns
- Unforeseen operational issues or infrastructure failures
Key Debates
Rate base growth exceeds 7% by H1 2025, maintaining ROE above 11.3%
Net Margin expands to 18% by Q4 2024 from operational efficiency gains
Rising interest rates depress Ameren's P/E below 19x by H1 2025